The biotech industry is buzzing with exciting changes, and a lot of it is thanks to one company: Moderna. Known for its COVID ...

作者：黄莺美国Moderna公司的专利官司持续不断。一周前，2024年10月12日，葛兰素史克公司（GSK）向美国特拉华州地方法院起诉Moderna，指控其COVID-19疫苗Spikevax以及今年5月份获得FDA批准的RNA呼吸道合胞病毒(RSV ...

Zylem Biosciences announced that Northwestern University has filed a lawsuit against Moderna (MRNA), alleging infringement of key patents ...

作者：黄莺俗话说人红是非多。在新冠疫情期间，凭借mRNA疫苗大获成功的Moderna公司，从年营收只有几千万美元的公司，一举跨入年营收200亿美元的公司行列。而这为其也带来了越来越多的专利纠纷。2021年，Moderna与美国国立卫生研究院的mRNA ...

TD Cowen维持对Moderna股票(NASDAQ: MRNA)的"持有"评级，目标价保持在60.00美元不变。 该公司在生物科技板块第三季度财报预览前发布了这一更新，并对Moderna的财务模型进行了调整。

In recent years, the biotech industry has seen a lot of exciting changes, and much of that is thanks to one company: Moderna.

Moderna ...

The latest trading session saw Moderna (MRNA) ending at $53.80, denoting a -0.55% adjustment from its last day's close. The stock's performance was behind the S&P 500's daily loss of 0.18%. Elsewhere, ...

Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...

格隆汇10月17日｜美国西北大学在特拉华州联邦法院对Moderna提起了一项新的专利诉讼。该诉讼称，Moderna在新冠疫苗Spikevax中未经许可使用西北大学开发的脂质纳米颗粒(LNP)技术，将脆弱的mRNA运输到人体内。Moderna的一位发言 ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

周三，美国西北大学 (Northwestern University)在特拉华州联邦法院对Moderna (MRNA.US)提起了一项新的专利诉讼，指控该公司滥用该校的创新成果来开发其重磅的新冠疫苗Spikevax。